Pathway Medical Technologies received $40M in a fourth round of funding. Their lead product is the Pathway Jetstream G2 atherectomy catheter:
“Jetstreamâ„¢ is designed to treat the entire spectrum of disease found in the PAD patient including hard and soft plaque, calcium, thrombus, and fibrotic lesions with consistent clinical results.”Â
